Clincosm LogoSign in Get a demo

Gastric Adenocarcinoma

Showing NaN - NaN of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma Trial in Worldwide (Evorpacept (ALX148),

Recruiting
  • Gastric Cancer
  • +2 more
  • Evorpacept (ALX148)
  • +3 more
  • Anaheim, California
  • +54 more
Jan 23, 2023

Gastric Adenocarcinoma Trial in Worldwide (Derazantinib, Derazantinib-paclitaxel-ramucirumab, Derazantinib-atezolizumab)

Completed
  • Gastric Adenocarcinoma
  • Orlando, Florida
  • +80 more
Jan 13, 2023

Small Cell Lung Cancer, NSCLC, Squamous, NSCLC, Non-squamous Trial in Worldwide (ladiratuzumab vedotin)

Recruiting
  • Small Cell Lung Cancer
  • +8 more
  • Chandler, Arizona
  • +65 more
Dec 19, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma Trial in Worldwide (tucatinib,

Active, not recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Birmingham, Alabama
  • +47 more
Oct 27, 2022

Gastric Adenocarcinoma, Malignant Melanoma Trial in Seoul (AZD6738, Durvalumab)

Active, not recruiting
  • Gastric Adenocarcinoma
  • Malignant Melanoma
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Gastric Adenocarcinoma Trial in Saint Louis, Seoul (MR guided radiation therapy, Blood for ctDNA)

Recruiting
  • Gastric Adenocarcinoma
  • MR guided radiation therapy
  • Blood for ctDNA
  • Saint Louis, Missouri
  • +1 more
Mar 15, 2022

Gastric Adenocarcinoma Trial in Seoul (TS-1 + cisplatin, radiation)

Recruiting
  • Gastric Adenocarcinoma
  • TS-1 + cisplatin
  • radiation
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
Apr 21, 2021

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Seoul (Ramucirumab, Paclitaxel)

Completed
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Seoul, Korea, Republic of
    Samsung Medical Center
Nov 17, 2020

Gastric Adenocarcinoma Trial in Seoul (Induction DCS chemo)

Completed
  • Gastric Adenocarcinoma
  • Induction DCS chemotherapy
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System, Yonsei Canc
Jan 10, 2020

Gastric Adenocarcinoma Trial in Seoul (docetaxel plus selumetinib)

Completed
  • Gastric Adenocarcinoma
  • docetaxel plus selumetinib
  • Seoul, Korea, Republic of
    Samsung Medical center
May 17, 2019

Gastric Adenocarcinoma Trial in Korea, Republic of (D2 distal subtotal gastrectomy, D1+ distal subtotal gastrectomy)

Unknown status
  • Gastric Adenocarcinoma
  • D2 distal subtotal gastrectomy
  • D1+ distal subtotal gastrectomy
  • Cheonan, Chuncheongnam-Do, Korea, Republic of
  • +49 more
Apr 18, 2016

Gastric Adenocarcinoma Trial in Seoul (DS, SP)

Unknown status
  • Gastric Adenocarcinoma
  • Seoul, Korea, Republic of
    Severance Hospital
Jun 1, 2013